Harness, formerly operating as Transine, broadens its approach to physiological protein upregulation through post-transcriptional modulation of protein synthesis Refined focus on neurodegenerative ...
Proceeds to be used to advance lead programme targeting FAN1 nuclease in Huntington’s Disease towards the clinic Harness Therapeutics was originally established as Transine Therapeutics in 2020 by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback